Last reviewed · How we verify
Midazolam, Ketamine and Sevoflurane
Midazolam, Ketamine and Sevoflurane is a Small molecule drug developed by Universidade Federal de Goias. It is currently in Phase 2 development. Also known as: Midazolam, Dormire ® (Cristalia Lab, Sao Paulo, Brazil), Ketamine, Ketamin ® (Cristalia Lab, Sao Paulo, Brazil), Sevoflurane, Sevocris ® (Cristalia Lab, Sao Paulo, Brazil).
At a glance
| Generic name | Midazolam, Ketamine and Sevoflurane |
|---|---|
| Also known as | Midazolam, Dormire ® (Cristalia Lab, Sao Paulo, Brazil), Ketamine, Ketamin ® (Cristalia Lab, Sao Paulo, Brazil), Sevoflurane, Sevocris ® (Cristalia Lab, Sao Paulo, Brazil) |
| Sponsor | Universidade Federal de Goias |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium (PHASE4)
- Magnesium Sulfate Versus Other Anesthesia Drugs to Reduce Agitation After Adenotonsillectomy in Pediatric Patients (NA)
- Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery (NA)
- GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries (PHASE3)
- Comparison Between the Effect of Dexmedetomidine _midazolam and ketamine_midazolam Combination (NA)
- Effect of Different Drugs on Emergency Delirium in Preschool Age Patient (NA)
- Anesthesia and Non-small Cell Lung Cancer Recurrence (PHASE4)
- Ketamine Versus Magnesium as Analgesic Adjuvants in Pediatric Adenotonsillectomy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Midazolam, Ketamine and Sevoflurane CI brief — competitive landscape report
- Midazolam, Ketamine and Sevoflurane updates RSS · CI watch RSS
- Universidade Federal de Goias portfolio CI
Frequently asked questions about Midazolam, Ketamine and Sevoflurane
What is Midazolam, Ketamine and Sevoflurane?
Midazolam, Ketamine and Sevoflurane is a Small molecule drug developed by Universidade Federal de Goias.
Who makes Midazolam, Ketamine and Sevoflurane?
Midazolam, Ketamine and Sevoflurane is developed by Universidade Federal de Goias (see full Universidade Federal de Goias pipeline at /company/universidade-federal-de-goias).
Is Midazolam, Ketamine and Sevoflurane also known as anything else?
Midazolam, Ketamine and Sevoflurane is also known as Midazolam, Dormire ® (Cristalia Lab, Sao Paulo, Brazil), Ketamine, Ketamin ® (Cristalia Lab, Sao Paulo, Brazil), Sevoflurane, Sevocris ® (Cristalia Lab, Sao Paulo, Brazil).
What development phase is Midazolam, Ketamine and Sevoflurane in?
Midazolam, Ketamine and Sevoflurane is in Phase 2.
Related
- Manufacturer: Universidade Federal de Goias — full pipeline
- Also known as: Midazolam, Dormire ® (Cristalia Lab, Sao Paulo, Brazil), Ketamine, Ketamin ® (Cristalia Lab, Sao Paulo, Brazil), Sevoflurane, Sevocris ® (Cristalia Lab, Sao Paulo, Brazil)
- Compare: Midazolam, Ketamine and Sevoflurane vs similar drugs
- Pricing: Midazolam, Ketamine and Sevoflurane cost, discount & access